First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markers ...

BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

Clinical-stage biotech Entropy Neurodynamics has received positive Phase 2a results for its psilocybin-based therapy in ...

Mikie Sherrill has picked Potosnak to lead the Department of Environmental Protection, a move that would put an environmental ...

CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...

THE PHILIPPINE Stock Exchange index (PSEi) may approach the 7,000 mark this year, supported by falling interest rates, steady economic conditions, and regulatory reforms, according to the Investment & ...

The rapid development and widespread use of artificial intelligence (AI) systems is posing new challenges for electricity ...

The iShares U.S. Home Construction ETF's seasonal trade offers discounted homebuilder exposure amid housing-policy catalysts ...